Tammy Furlong - 15 Feb 2025 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Yang, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
15 Feb 2025
Net transactions value
-$1,927
Form type
4
Filing time
19 Feb 2025, 16:20:06 UTC
Previous filing
19 Nov 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELEV Common Stock Options Exercise +9,375 +665% 10,785 15 Feb 2025 Direct F1
transaction ELEV Common Stock Tax liability $1,867 -2,780 -26% $0.6717 8,005 15 Feb 2025 Direct
transaction ELEV Common Stock Options Exercise +300 +3.7% 8,305 15 Feb 2025 Direct F1
transaction ELEV Common Stock Tax liability $59.78 -89 -1.1% $0.6717 8,216 15 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +275,000 $0.000000 275,000 15 Feb 2025 Common Stock 275,000 $0.6717 Direct F2
transaction ELEV Restricted Stock Unit Options Exercise $0 -9,375 -25% $0.000000 28,125 15 Feb 2025 Common Stock 9,375 Direct F1, F3, F4
transaction ELEV Restricted Stock Unit Options Exercise $0 -300 -11% $0.000000 2,400 15 Feb 2025 Common Stock 300 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 The stock option vests as to 25% of the total shares on February 15, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F3 25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F4 The RSUs do not expire; they either vest or are canceled prior to the vesting date.
F5 25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.